P. Pertel

发表

Randomized Controlled Trial of Moxifloxacin Compared With Piperacillin–Tazobactam and Amoxicillin–Clavulanate for the Treatment of Complicated Intra-abdominal Infections

M. Malangoni, James X. Song, S. Choudhri, 2006, Annals of surgery.

Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus.

J. Phair, J. Chmiel, R. Hirschtick, 1992, Journal of acquired immune deficiency syndromes.

Safety, pharmacokinetics and causal prophylactic efficacy of KAF156 in a Plasmodium falciparum human infection study.

J. Kublin, A. Vaughan, S. Kappe, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Risk factors for a poor outcome after therapy for acute pyelonephritis

D. Haverstock, P. Pertel, Peter E. Pertel, 2006, BJU international.

Effects of prior effective therapy on the efficacy of daptomycin and ceftriaxone for the treatment of community-acquired pneumonia.

R. Arbeit, C. Fogarty, J. Alder, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antimalarial Activity of KAF156 in Falciparum and Vivax Malaria.

Baldur P Magnusson, M. Sultan, Ming-Sin Cheung, 2016, The New England journal of medicine.

Efficacy and Safety of an Inhaled Anti-TSLP Antibody Fragment in Adults with Mild Atopic Asthma

H. Watz, L. Boulet, P. O'Byrne, 2020 .

Eradication of common pathogens at days 2, 3 and 4 of moxifloxacin therapy in patients with acute bacterial sinusitis

H. Ariza, R. Rojas, J. Herrington, 2006, BMC Ear, Nose and Throat Disorders.

Acute bacterial maxillary sinusitis: time to symptom resolution and return to normal activities with moxifloxacin

K. Keating, A. Benson, J. Adelglass, 2008, International journal of clinical practice.

Pharmacokinetics of LFF571 and Vancomycin in Patients with Moderate Clostridium difficile Infections

J. Praestgaard, J. Leeds, S. Bhansali, 2014, Antimicrobial Agents and Chemotherapy.

A First-in-Human, Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study To Assess the Safety and Tolerability of LFF571 in Healthy Volunteers

J. Praestgaard, J. Leeds, Jenny C. Yang, 2012, Antimicrobial Agents and Chemotherapy.

A First-inHuman , Randomized , Double-Blind , Placebo-Controlled , Single-and Multiple-Ascending Oral Dose Study To Assess the Safety and Tolerability of LFF 571 in Healthy Volunteers

J. Praestgaard, J. Leeds, Jenny C. Yang, 2012 .

Complicated Urinary Tract Infections Treated with Extended-Release Ciprofloxacin with Emphasis on Pseudomonas aeruginosa

D. Haverstock, J. Herrington, A. Benson, 2007, Journal of chemotherapy.

Human Herpesvirus 8 Glycoprotein B (gB), gH, and gL Can Mediate Cell Fusion

P. Pertel, 2002, Journal of Virology.

Phase 2 Study of Anti-Human Cytomegalovirus Monoclonal Antibodies for Prophylaxis in Hematopoietic Cell Transplantation

A. Logan, E. Holler, L. Akard, 2020, Antimicrobial Agents and Chemotherapy.

Intractable hiccups induced by the use of megestrol acetate.

P. Pertel, M. Till, 1998, Archives of internal medicine.

Partial resistance to gD-mediated interference conferred by mutations affecting herpes simplex virus type 1 gC and gK

P. Spear, P. Pertel, 1997, Journal of virology.

Human herpesvirus-8 glycoprotein B interacts with Epstein-Barr virus (EBV) glycoprotein 110 but fails to complement the infectivity of EBV mutants.

R. Longnecker, P. Spear, P. Pertel, 1998, Virology.

Pharmacokinetics and safety of multiple doses of daptomycin 6 mg/kg in noninfected adults undergoing hemodialysis or continuous ambulatory peritoneal dialysis.

S. Swan, S. Yankelev, P. Pertel, 2011, Clinical nephrology.

Safety, tolerability, pharmacokinetics, and efficacy of an interleukin-2 agonist among HIV-infected patients receiving highly active antiretroviral therapy.

B. Gazzard, R. Davey, M. Saag, 2008, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Linezolid treatment for osteomyelitis due to vancomycin-resistant Enterococcus faecium.

R. Wixson, P. Pertel, M. Till, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Sequential intravenous/oral moxifloxacin versus intravenous piperacillin-tazobactam followed by oral amoxicillin-clavulanate for the treatment of complicated skin and skin structure infection.

James X. Song, P. Giordano, S. Kowalsky, 2005, International journal of antimicrobial agents.

A First-in-Human Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study of Novel Antimalarial Spiroindolone KAE609 (Cipargamin) To Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers

Baldur P Magnusson, G. Lefèvre, J. Jain, 2014, Antimicrobial Agents and Chemotherapy.

A First-in-Human Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Oral Dose Study of Novel Imidazolopiperazine KAF156 To Assess Its Safety, Tolerability, and Pharmacokinetics in Healthy Adult Volunteers

Baldur P Magnusson, F. Leong, T. Diagana, 2014, Antimicrobial Agents and Chemotherapy.

Modified entry and syncytium formation by herpes simplex virus type 1 mutants selected for resistance to heparin inhibition.

P. Spear, P. Pertel, 1996, Virology.

Cell fusion induced by herpes simplex virus glycoproteins gB, gD, and gH-gL requires a gD receptor but not necessarily heparan sulfate.

P. Spear, M. Parish, A. Fridberg, 2001, Virology.

The efficacy and safety of daptomycin vs. vancomycin for the treatment of cellulitis and erysipelas

W. Martone, B. Eisenstein, P. Bernardo, 2009, International journal of clinical practice.

Clinical Characteristics and Functional Outcomes of West Nile Fever

Roderick C. Jones, S. Gerber, W. Paul, 2004, Annals of Internal Medicine.

A First-in-Human Study To Assess the Safety and Pharmacokinetics of Monoclonal Antibodies against Human Cytomegalovirus in Healthy Volunteers

Baldur P Magnusson, Yinuo Pang, F. Segal, 2016, Antimicrobial Agents and Chemotherapy.

The Value, Qualification, and Regulatory Use of Surrogate End Points in Drug Development

Stephen A. Williams, J. Wagner, C. Girman, 2009, Clinical pharmacology and therapeutics.

A first-in-human randomized, double-blind, placebo-controlled, single- and multiple-ascending oral dose study of novel spiroindolone KAE609, to assess the safety, tolerability and pharmacokinetics in healthy adult volunteers

Baldur P Magnusson, G. Lefèvre, J. Jain, 2014, Malaria Journal.

Multicenter, Randomized Clinical Trial To Compare the Safety and Efficacy of LFF571 and Vancomycin for Clostridium difficile Infections

Jens Praestgaard, Karl Weiss, J. Praestgaard, 2014, Antimicrobial Agents and Chemotherapy.

Late Breaking Abstract - Efficacy of CSJ117 on allergen-induced asthmatic responses in mild atopic asthma patients

L. Boulet, P. O'Byrne, J. Hohlfeld, 2020 .

Adverse reactions to dapsone in persons infected with human immunodeficiency virus.

R. Hirschtick, P. Pertel, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma

H. Watz, L. Boulet, P. O'Byrne, 2023, European Respiratory Journal.

Effects of prior effective therapy on the efficacy of daptomycin and ceftriaxone for the treatment of community-acquired pneumonia.

R. Arbeit, C. Fogarty, J. Alder, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Value, Qualification, and Regulatory Use of Surrogate End Points in Drug Development

Stephen A. Williams, J. Wagner, C. Girman, 2009, Clinical pharmacology and therapeutics.